Bosh sahifaNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Yopilish kursi
0,23 $
Kunlik diapazon
0,23 $ - 0,24 $
Yillik diapazon
0,17 $ - 0,48 $
Bozor kapitalizatsiyasi
360,14 mln USD
Oʻrtacha hajm
3,59 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 200,00 ming | -43,98% |
Joriy xarajat | 7,07 mln | 0,60% |
Sof foyda | -26,83 mln | -38,48% |
Sof foyda marjasi | -13,41 ming | -147,19% |
Har bir ulushga tushum | — | — |
EBITDA | -13,87 mln | 3,39% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 4,56 mln | 55,15% |
Jami aktivlari | 30,61 mln | 4,39% |
Jami passivlari | 125,86 mln | 34,52% |
Umumiy kapital | -95,25 mln | — |
Tarqatilgan aksiyalar | 1,54 mlrd | — |
Narxi/balansdagi bahosi | -3,34 | — |
Aktivlardan daromad | -119,02% | — |
Kapitaldan daromad | 204,40% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -26,83 mln | -38,48% |
Operatsiyalardan naqd pul | -13,89 mln | -68,75% |
Sarmoyadan naqd pul | -513,00 ming | -191,48% |
Moliyadan naqd pul | 11,56 mln | -0,53% |
Naqd pulning sof oʻzgarishi | 244,00 ming | 320,69% |
Boʻsh pul | -4,95 mln | -23,91% |
Haqida
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
Tashkil etilgan
1-yan, 1998
Sayt
Xodimlar soni
25
